Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
BuchKartoniert, Paperback
255 Seiten
Englisch
Springererschienen am29.07.20242023
Tumors are classified as WHO grades 1, 2 or 3 based largely on histopathological features such as mitotic activity, presence of brain invasion, and other atypical features.mehr
Verfügbare Formate
BuchGebunden
EUR160,49
BuchKartoniert, Paperback
EUR160,49

Produkt

KlappentextTumors are classified as WHO grades 1, 2 or 3 based largely on histopathological features such as mitotic activity, presence of brain invasion, and other atypical features.
Details
ISBN/GTIN978-3-031-29752-6
ProduktartBuch
EinbandartKartoniert, Paperback
Verlag
Erscheinungsjahr2024
Erscheinungsdatum29.07.2024
Auflage2023
ReiheAdvances in Experimental Medicine and Biology
Seiten255 Seiten
SpracheEnglisch
Gewicht525 g
IllustrationenXVII, 255 p. 55 illus., 33 illus. in color.
Artikel-Nr.56588347
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Chapter 1. Introduction and History of Meningiomas.- Chapter 2. Clinical Presentation and Prognosis.- Chapter 3. Imaging Characteristics of Meningiomas.- Chapter 4. Histopathology of Meningiomas.- Chapter 5. Skull Base Meningiomas.- Chapter 6. Spinal Meningiomas.- Chapter 7. Surgical Therapies.- Chapter 8. Radiation Therapies.- Chapter 9. Illustrative Cases.- Chapter 10. Advances in CNS Tumor Classification.- Chapter 11. Genomic Landscape.- Chapter 12. Radiation-Induced Meningiomas.- Chapter 13. Meningioma Predisposing Syndromes.- Chapter 14. Epigentic Landscape.- Chapter 15. Immune Profile.- Chapter 16. PDX Models/Mouse Models/Cell Lines.- Chapter 17. Novel Medical Therapies .- Chapter 18. Quality of Life in Menigioma Patients .- Chapter 19. Illustrative Cases: Revisited with Adjuvant Molecular Data .- Chapter 20. Future Directions in Management.mehr

Autor

Gelareh Zadeh is a Professor at the Department of Surgery University of Toronto. She is a Neurosurgeon-Scientist at Toronto Western Hospital, University Health Network. She was most recently appointed as the Wilkins Family Chair in Brain Tumor Research. Her research laboratory is focused on studying the molecular mechanisms of glioma angiogenesis and molecular regulators of tumour metabolism.

Rolan Goldbrunner is Professor in the Department of General Neurosurgery and Head of the Center for Neurosurgery at the University of Cologne in Germany. He is the Past President of the German Society for Neurosurgery. His special focus is on brain tumours.

Boris Krischek is a Neurosurgeon at Les Hôpitaux Robert Schuman in Luxembourg and Professor in the Department of General Neurosurgery at the University of Cologne in Germany.

Farshad Nassiri is a Neurosurgery Resident at University of Toronto and a member of Zadeh Lab.
Weitere Artikel von
Herausgegeben:Zadeh, Gelareh
Weitere Artikel von
Goldbrunner, Roland